ESR1 and cancer: The Y537 and D538 ER mutants are also phosphorylated on S118 by the TFIIH kinase, cyclin-dependent kinase (CDK)7 in an estrogen-independent manner, which may be the possible reason for endocrine resistance by potentiating transcriptional activity of mutant ER-driven cancer (55).